n17350
onchilles pharma
['n17350']
at #aacr23 next week we re presenting our latest data on lead drug candidate, n17350 a first-in-class biologic that possesses unique characteristics of an ideal cancer drug and is inspired by the immunobiology of #neutrophils #elane pathway. 